Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Start-Up Applying Artificial Intelligence to New Drug Uses

A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs. . . . → Read More: Start-Up Applying Artificial Intelligence to New Drug Uses

Glaxo Using Artificial Intelligence for Drug Discovery

Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets. . . . → Read More: Glaxo Using Artificial Intelligence for Drug Discovery

Start-Up to Offer Neuro Disorder Speech Analytics App

A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders. . . . → Read More: Start-Up to Offer Neuro Disorder Speech Analytics App

Organ Chips to be Studied on Space Station

A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station. . . . → Read More: Organ Chips to be Studied on Space Station

Engineered Algae Doubles Bio-Oil Content

An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow. . . . → Read More: Engineered Algae Doubles Bio-Oil Content

Exosuit Prototype Unveiled for Stroke Survivors

An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June. . . . → Read More: Exosuit Prototype Unveiled for Stroke Survivors

Coalition to Make 10,000 Open-Access Synthetic Genes

A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes

Institutions to Apply AI Models to Type 1 Diabetes

A children’s hospital and diabetes research center are evaluating techniques using artificial intelligence to better identify and manage the care of people with type 1 diabetes. . . . → Read More: Institutions to Apply AI Models to Type 1 Diabetes

Cancer Center to Test Focused Radiation Therapy

MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy. . . . → Read More: Cancer Center to Test Focused Radiation Therapy

Pharma Company Seeking Digital Tech Partners

Drug maker AstraZeneca is seeking partners to develop solutions with digital technology to accelerate clinical trials and improve health outcomes for patients. . . . → Read More: Pharma Company Seeking Digital Tech Partners